{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:07:27Z","timestamp":1725469647877},"publisher-location":"Chichester, UK","reference-count":129,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001478.pub2","type":"reference-entry","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T20:38:24Z","timestamp":1153255104000},"source":"Crossref","is-referenced-by-count":2,"title":["Acellular vaccines for preventing whooping cough in children"],"prefix":"10.1002","author":[{"given":"Owen","family":"Tinnion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD001478.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02724936.1996.11747802","article-title":"Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana","volume":"16","author":"Afari","year":"1996","journal-title":"Ann Trop Paediatr"},{"key":"10.1002\/14651858.CD001478.pub2-BIB2|cit2","first-page":"955","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events [published erratum appears in Lancet 1988 May 28;1(8596):1238]","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archpedi.1991.02160110077024","article-title":"Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions","volume":"145","author":"Blackwelder","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1002\/14651858.CD001478.pub2-BIB4|cit4","first-page":"1994","article-title":"[Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial] Skyddseffekten av tva acellulara kikhostevacciner i en dubbelblind placebokontrollerad klinisk provning","volume":"85","author":"Kallings","year":"1988","journal-title":"Lakartidningen"},{"key":"10.1002\/14651858.CD001478.pub2-BIB5|cit5","first-page":"143","article-title":"Invasive bacterial infections during an efficacy trial of acellular pertussis vaccines--implications for future surveillance in pertussis vaccine programmes","volume":"13","author":"Olin","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1002\/14651858.CD001478.pub2-BIB6|cit6","unstructured":"Olin P Storsaeter J Linder T Winter C S\u00f6nstenby C A Clinical Trial of Acellular Pertussis Vaccines in Sweden Technical Report 1988 1988215677"},{"key":"10.1002\/14651858.CD001478.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0264-410X(90)90246-I","article-title":"Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial","volume":"8","author":"Storsaeter","year":"1990","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00006454-198809000-00008","article-title":"Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden","volume":"7","author":"Storsaeter","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD001478.pub2-BIB9|cit9","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB10|cit10","first-page":"99","article-title":"Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB11|cit11","unstructured":"Olin P Gustafsson L Rasmussen H Hallander H Heijbel H Gottfarb P Efficacy trial of acellular pertussis vaccines. Technical report trial II with preplanned analysis of efficacy, immunogenicity and safety Swedish Institute for Infectious Disease Control 1997"},{"key":"10.1002\/14651858.CD001478.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/157.4.731","article-title":"Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants","volume":"157","author":"Anderson","year":"1988","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub2-BIB14|cit14","first-page":"556","article-title":"Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children [published errata appear in Am J Dis Child 1992 Jul;1 46(7):802 and 1992 Sep;146(9):1084]","volume":"146","author":"Bernstein","year":"1992","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1542\/peds.93.4.656","article-title":"Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants","volume":"93","author":"Bernstein","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00006454-199701000-00012","article-title":"Safety and immunogenicity of Chiron\/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers","volume":"16","author":"Black","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1542\/peds.82.3.293","article-title":"Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial","volume":"82","author":"Blennow","year":"1988","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub2-BIB18|cit18","first-page":"185","article-title":"Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6","volume":"65","author":"Blennow","year":"1986","journal-title":"Dev Biol Stand"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01962341","article-title":"Protective effect of acellular pertussis vaccines","volume":"7","author":"Blennow","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001478.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(05)82442-4","article-title":"Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody","volume":"117","author":"Blumberg","year":"1990","journal-title":"J Pediatr"},{"key":"10.1002\/14651858.CD001478.pub2-BIB21|cit21","first-page":"51","article-title":"Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups","volume":"73","author":"Cherry","year":"1991","journal-title":"Dev Biol Stand"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3476(05)80727-9","article-title":"Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group","volume":"119","author":"Blumberg","year":"1991","journal-title":"J Pediatr"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB24|cit23","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1093\/infdis\/174.Supplement_3.S270","article-title":"The multicenter acellular pertussis trial: an overview","volume":"174","author":"Decker","year":"1996","journal-title":"J Infect Dis"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub2-BIB23|cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archpedi.1986.02140230037024","article-title":"Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components","volume":"140","author":"Edwards","year":"1986","journal-title":"Am J Dis Child"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archpedi.1986.02140230037024","article-title":"Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components","volume":"140","author":"Edwards","year":"1986","journal-title":"Am J Dis Child"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3476(05)80328-2","article-title":"Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children [published erratum appears in J Pediatr 1993 Nov;123(5):842]","volume":"121","author":"Feldman","year":"1992","journal-title":"J Pediatr"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"269-75, 284","DOI":"10.1097\/00007611-199303000-00002","article-title":"Primary immunization series for infants: comparison of two-component acellular and standard whole-cell pertussis vaccines combined with diphtheria-tetanus toxoids","volume":"86","author":"Feldman","year":"1993","journal-title":"South Med J"},{"issue":"7","key":"10.1002\/14651858.CD001478.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00006454-199207000-00005","article-title":"Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children","volume":"11","author":"Glode","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD001478.pub2-BIB36|cit36","first-page":"77","article-title":"Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials","volume":"89","author":"Ciofi degli Atti","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB38|cit37","first-page":"55","article-title":"Italian trial on acellular pertussis vaccines","volume":"89","author":"Greco","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB37|cit38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001478.pub2-BIB39|cit39","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB40|cit40","first-page":"105","article-title":"Common side effects in the Italian and Stockholm I trials","volume":"89","author":"Tozzi","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB41|cit41","first-page":"77","article-title":"Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials","volume":"89","author":"Ciofi degli Atti","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB42|cit42","unstructured":"Gustaffson L Hallander H Olin P Reizenstein E Storsaeter J Efficacy trial of acellular pertussis vaccines. Technical report Trial I with results of preplanned analysis of safety, efficacy and immunogenicity Swedish Institute for Infectious Disease Control 1995"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [see comments]","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001478.pub2-BIB44|cit44","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB45|cit45","first-page":"52","article-title":"Efficacy trial of acellular pertussis vaccines; trial I","volume":"89","author":"Olin","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB46|cit46","first-page":"105","article-title":"Common side effects in the Italian and Stockholm I trials","volume":"89","author":"Tozzi","year":"1997","journal-title":"Dev Biol Stand"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archpedi.1994.02170110106025","article-title":"Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities","volume":"148","author":"Halperin","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archpedi.1994.02170110106025","article-title":"Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities","volume":"148","author":"Halperin","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199509000-00012","article-title":"Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age","volume":"14","author":"Halperin","year":"1995","journal-title":"Pediatr I nfect Dis J"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0264-410X(95)00250-5","article-title":"Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life","volume":"14","author":"Halperin","year":"1996","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(94)90014-0","article-title":"Comparative study of Lederle\/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany","volume":"12","author":"Heininger","year":"1994","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01955054","article-title":"Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children","volume":"152","author":"Kanra","year":"1993","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01955054","article-title":"Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children","volume":"152","author":"Kanra","year":"1993","journal-title":"Eur J Pediatr"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub2-BIB54|cit54","first-page":"872","article-title":"A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children","volume":"140","author":"Lewis","year":"1986","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB55|cit55","first-page":"290","article-title":"Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children [published erratum appears in Am J Dis Child 1993 Jun;1 47(6):626]","volume":"147","author":"Marcinak","year":"1993","journal-title":"Am J Dis Child"},{"issue":"8733","key":"10.1002\/14651858.CD001478.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0140-6736(91)90735-8","article-title":"Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens","volume":"337","author":"Miller","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub2-BIB57|cit57","first-page":"51","article-title":"Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups","volume":"73","author":"Cherry","year":"1991","journal-title":"Dev Biol Stand"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD001478.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1203\/00006450-199004000-00007","article-title":"Metabolic and hematologic effects and immune complex formation related to pertussis immunization","volume":"27","author":"Mink","year":"1990","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archpedi.1990.02150250047029","article-title":"Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children","volume":"144","author":"Morgan","year":"1990","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB60|cit60","first-page":"295","article-title":"Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants","volume":"1 47","author":"Pichichero","year":"1993","journal-title":"Am J Dis Child"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00365549609049068","article-title":"Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine","volume":"28","author":"Pichichero","year":"1996","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","article-title":"A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children","volume":"100","author":"Pichichero","year":"1997","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(05)83181-6","article-title":"Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine","volume":"124","author":"Podda","year":"1994","journal-title":"J Pediatr"},{"key":"10.1002\/14651858.CD001478.pub2-BIB64|cit64","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB65|cit65","first-page":"113","article-title":"Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group","volume":"89","author":"Schmitt-Grohe","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB66|cit66","first-page":"58","article-title":"A comparative efficacy trial in Germany in which infants received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine","volume":"89","author":"Stehr","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB67|cit67","first-page":"83","article-title":"Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group","volume":"89","author":"Uberall","year":"1997","journal-title":"Dev Biol Stand"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub2-BIB68|cit68","first-page":"854","article-title":"Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines","volume":"147","author":"Rothstein","year":"1993","journal-title":"Am J Dis Child"},{"issue":"12","key":"10.1002\/14651858.CD001478.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF01690510","article-title":"Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants","volume":"15","author":"Simondon","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1002\/14651858.CD001478.pub2-BIB70|cit70","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB71|cit71","first-page":"91","article-title":"The Senegal pertussis trial: safety and surveillance of adverse reactions","volume":"89","author":"Preziosi","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB72|cit72","first-page":"63","article-title":"Senegal pertussis trial","volume":"89","author":"Simondon","year":"1997","journal-title":"Dev Biol Stand"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB73|cit73","first-page":"155","article-title":"[An observation on immunization reaction and serological effect of adsorbed purified pertussis vaccine]","volume":"14","author":"Tian","year":"1993","journal-title":"Chung Hua Liu Hsing Ping Hsueh Tsa Chih"},{"key":"10.1002\/14651858.CD001478.pub2-BIB74|cit74","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB75|cit75","first-page":"109","article-title":"Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial","volume":"89","author":"Taranger","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB77|cit76","first-page":"49","article-title":"The Gothenburg pertussis vaccine study","volume":"89","author":"Trollfors","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB76|cit77","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0264-410X(94)90196-1","article-title":"Study of pertussis vaccines in infants: comparison of response to acellular pertussis DTP vaccines containing 25 micrograms of FHA and either 25 or 8 micrograms of PT with response to whole-cell pertussis DTP vaccine","volume":"12","author":"Vanura","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpedi.1994.02170050061011","article-title":"Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates","volume":"148","author":"Annunziato","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"17","key":"10.1002\/14651858.CD001478.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/0264-410X(95)00137-P","article-title":"Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States","volume":"13","author":"Bernstein","year":"1995","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02724936.1995.11747762","article-title":"Pertussis immunization with acellular vaccines in Ghanaian children","volume":"15","author":"Hori","year":"1995","journal-title":"Ann Trop Paediatr"},{"key":"10.1002\/14651858.CD001478.pub2-BIB82|cit82","first-page":"275","article-title":"Two trials of an acellular DTP vaccine in comparison with a whole-cell DTP vaccine in infants: evaluation of two PT doses and two vaccination schedules","volume":"73","author":"Just","year":"1991","journal-title":"Dev Biol Stand"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0264-410X(96)00112-0","article-title":"Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance","volume":"15","author":"Miller","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1542\/peds.71.2.200","article-title":"Evaluation of the pertussis components of diphtheria-tetanus-pertussis vaccine","volume":"71","author":"Murphy","year":"1983","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006454-198704000-00004","article-title":", McLinn S, Trevino Scatterday B, Nelson JD. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children","volume":"6","author":"Pichichero","year":"1987","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006454-199403000-00005","article-title":"Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children","volume":"13","author":"Pichichero","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD001478.pub2-BIB87|cit87","first-page":"145","article-title":"Pertussis notifications in Australia, 1991 to 1997","volume":"21","author":"Andrews","year":"1997","journal-title":"Commun Dis Intell"},{"key":"10.1002\/14651858.CD001478.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/bmj.2.6078.5-a","article-title":"Whooping-cough immunisation, editorial","volume":"2","author":"Anonymous","year":"1977","journal-title":"Br Med J"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001478.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1093\/infdis\/174.Supplement_3.S264","article-title":"Acellular pertussis vaccines developed in Japan and their application for disease control","volume":"174","author":"Aoyama","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1002\/14651858.CD001478.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(05)62352-5","article-title":"Does blinding of readers affect the results of meta-analyses?","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub2-BIB91|cit91","first-page":"653","article-title":"Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience","volume":"11","author":"Binkin","year":"1992","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archpedi.1991.02160110077024","article-title":"Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions","volume":"145","author":"Blackwelder","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1002\/14651858.CD001478.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"N Eng J Med"},{"key":"10.1002\/14651858.CD001478.pub2-BIB94|cit94","first-page":"198","article-title":"Report of the Committee on Infectious Diseases","volume-title":"Red Book","year":"1982"},{"key":"10.1002\/14651858.CD001478.pub2-BIB95|cit95","first-page":"7","article-title":"Report of the Committee on Infectious Diseases","volume-title":"Red Book","year":"1988"},{"key":"10.1002\/14651858.CD001478.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1542\/peds.88.2.397","article-title":"The relationship between pertussis vaccine and brain damage: reassessment","volume":"88","year":"1991","journal-title":"Pediatrics"},{"article-title":"Report of the Committee on Infectious Diseases of the American Academy of Pediatrics","volume-title":"Red Book","year":"1994","key":"10.1002\/14651858.CD001478.pub2-BIB97|cit97"},{"article-title":"Report of the Committee on Infectious Diseases of the American Academy of Pediatrics","volume-title":"Red Book","year":"1991","key":"10.1002\/14651858.CD001478.pub2-BIB98|cit98"},{"key":"10.1002\/14651858.CD001478.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimionian","year":"1986","journal-title":"Controlled Clin Trials"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub2-BIB102|cit102","first-page":"123","article-title":"Implications of different study designs for the evaluation of acellular pertussis vaccines","volume":"89","author":"Fine","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB103|cit103","first-page":"379","article-title":"Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease?","volume":"89","author":"Granoff","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/sim.4780090307","article-title":"Bias in the one-step method for pooling study results","volume":"9","author":"Greenland","year":"1990","journal-title":"Stat Med"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006454-198804000-00005","article-title":"Efficacy and safety of acellular pertussis vaccine in Aichi Prefecture, Japan","volume":"7","author":"Isomura","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD001478.pub2-BIB106|cit106","first-page":"3","article-title":"Pertussis: a worldwide problem","volume":"89","author":"Ivanoff","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB107|cit107","first-page":"1","article-title":"Epidemiology of pertussis in Japan","volume":"13","author":"Kimura","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1002\/14651858.CD001478.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-280880-7.50008-0","article-title":"Pertussis","volume-title":"Bacterial Vaccines","author":"Manclark","year":"1984"},{"key":"10.1002\/14651858.CD001478.pub2-BIB109|cit109","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/14651858.CD001478.pub2-BIB110|cit110","first-page":"389","article-title":"Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children","volume":"61","author":"Miller","year":"1985","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB111|cit111","first-page":"145","article-title":"Severe neurological illness: further analyses of the British National Childhood Encephalopathy Study","volume":"13","author":"Miller","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1002\/14651858.CD001478.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/clinids\/14.2.464","article-title":"A search for Bordetella pertussis infection in university students","volume":"14","author":"Mink","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1002\/14651858.CD001478.pub2-BIB113|cit113","first-page":"89","article-title":"Pertussis and pertussis vaccine in the developing world","volume":"13","author":"Mortimer","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1002\/14651858.CD001478.pub2-BIB114|cit114","first-page":"78","article-title":"Pertussis Vaccine","volume-title":"Canadian Immunization Guide","year":"1989"},{"volume-title":"Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine","year":"1989","author":"Petitti","key":"10.1002\/14651858.CD001478.pub2-BIB115|cit115"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub2-BIB116|cit116","first-page":"588","article-title":"Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines","volume":"96","author":"Pichichero","year":"1995","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub2-BIB117|cit117","doi-asserted-by":"crossref","first-page":"522","DOI":"10.5694\/j.1326-5377.1987.tb120392.x","article-title":"Bordetella pertussis infection: a cause of persistent cough in adults","volume":"146","author":"Robertson","year":"1987","journal-title":"Med J Aust"},{"key":"10.1002\/14651858.CD001478.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2307\/2531052","article-title":"Estimators of the Mantel-Haenszel variance consistent with both sparse and large-strata limiting models","volume":"42","author":"Robins","year":"1986","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD001478.pub2-BIB119|cit119","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006454-198704000-00005","article-title":"Pertussis in Sweden after the cessation of general immunization in 1979","volume":"6","author":"Romanus","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD001478.pub2-BIB120|cit120","article-title":"Cochrane Collaboration Handbook","volume-title":"The Cochrane Library","author":"Sackett","year":"1996"},{"issue":"8369","key":"10.1002\/14651858.CD001478.pub2-BIB121|cit121","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub2-BIB122|cit122","first-page":"327","article-title":"Japanese experience with 60 million doses of acellular pertussis vaccines","volume":"89","author":"Sato","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1002\/14651858.CD001478.pub2-BIB123|cit123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199503000-00008","article-title":"Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany","volume":"14","author":"Schl\u00e4pfer","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD001478.pub2-BIB124|cit124","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1093\/infdis\/174.Supplement_3.S287","article-title":"Acellular pertussis vaccines: the rationale for an efficacy trial in Germany","volume":"174 Suppl 3","author":"Schmitt","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1002\/14651858.CD001478.pub2-BIB125|cit125","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/clinids\/21.4.860","article-title":"Pertussis in German adults","volume":"21","author":"Schmitt-Groh\u00e9","year":"1995","journal-title":"Cin Infect Dis"},{"key":"10.1002\/14651858.CD001478.pub2-BIB126|cit126","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00006454-199702000-00003","article-title":"Trollfors B, Lagerg\u00e5rd, Lind L, Sund VH, Zackrisson G et al. Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants","volume":"16","author":"Taranger","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/14651858.CD001478.pub2-BIB127|cit127","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/infdis\/159.2.211","article-title":"Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination","volume":"159","author":"Thomas","year":"1989","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1542\/peds.81.3.345","article-title":"Neurologic events following diphtheria-tetanus-pertussis immunization","volume":"81","author":"Walker","year":"1988","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub2-BIB129|cit129","unstructured":"WHO WHO meeting on case definitions of pertussis MIN\/EPI\/PERT\/91 1991 4 5"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001478.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:06:12Z","timestamp":1683518772000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001478.pub2"}},"subtitle":[],"editor":[{"given":"Mark","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":129,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001478.pub2","relation":{},"subject":[],"published":{"date-parts":[[2006,7,19]]}}}